Biond™ pharmaceutical-grade ingredients

Biond™ - Taking biopharma beyond today. Ready for tomorrow.

dsm-firmenich’s Biond™ ingredients portfolio helps biopharma innovators bring next-generation therapies to market with greater control throughout manufacturing, consistency in quality, and confidence in performance. Built on pharmaceutical-grade ingredients, scientific rigor, and decades of pharma expertise, Biond™ gives you a future-ready foundation for cell culture media and biologic applications.

The biopharma market is moving fast. Are your ingredients keeping up?

Biopharma innovation is accelerating, and complexity is climbing right alongside it. As therapies grow more advanced, the ingredients underpinning them face increasingly demanding requirements.

Many innovators have long relied on non-pharma or technical-grade ingredients for cell culture media and biologic applications. These standards may no longer hold up. They can leave gaps in transparency, reliability, and traceability just when quality and regulatory expectations are rising.

To navigate the biopharma landscape, you need confidence that your development programs can meet today's requirements and adapt as standards evolve. That means trusting the quality, documentation, and supply behind every ingredient in your process.

Why Biond™ is built for tomorrow

Biond™ gives you a stronger base for long-lasting success in biopharma. Here's how.

Beyond ingredients

More than materials

High-quality ingredients are the start, not the finish. What sets a partner apart is what happens around them.

Expertise that guides

Our global pharma team brings decades of experience in the scientific, quality, regulatory, and sustainability requirements needed to operate in this highly regulated industry. We understand your world, and we translate that understanding into practical guidance that helps you make faster, better-informed decisions.

Built for what's next

As biopharma continues to change, we help you adapt, maintain momentum, and build resilience for the demands ahead. Together, we can shape the next generation of biopharma therapies and elevate patient care together. 

Frequently asked questions

Biond™ is a family of pharmaceutical-grade ingredients from dsm-firmenich, designed for biopharma applications. It helps biopharma innovators bring next-generation therapies to market with greater control throughout manufacturing, consistency in quality, and confidence in performance.

Biond™ ingredients are backed by pharmaceutical-level controls, scientific rigor, transparent documentation, and full traceability. Where non-pharma or technical-grade standards may leave gaps in consistency and compliance, Biond™ offers a future-ready foundation designed for reproducible performance in demanding biopharma applications.

Biond™ supports cell culture media and biologic applications. Vitamins and other ingredients in these processes play key roles in cell growth and productivity, and Biond™ is designed to deliver the reproducibility and functionality these applications require.

Vitamins are an essential component of the media used to support cell growth and productivity. They act as co-factors in essential metabolism reactions and provide antioxidant protection, among other functions. Their quality and performance can directly influence the consistency and reliability of your processes.

To learn more, connect with our partner Brenntag and explore its BYPHAR Excel portfolio, which includes Biond™ pharmaceutical-grade-ingredients for biopharma applications.

Commercialized in partnership with Brenntag.

To ensure a seamless customer experience, dsm-firmenich’s Biond™ offering is available globally and exclusively through Brenntag’s biopharma product portfolio, BYPHAR. The BYPHAR portal provides access to detailed product information, sample requests, and technical support via a trusted global biopharma distribution ne

Related articles

  • Breaking barriers in biologic formulation development through collaboration

    Breaking barriers in biologic formulation development through collaboration

    Discover how dsm-firmenich and ten23 health are transforming biologic formulation development through advanced excipient options.

  • Ask-the-Expert: What does new clinical evidence mean for CBtru® and oral solid drug delivery?

    Ask-the-Expert: What does new clinical evidence mean for CBtru® and oral solid drug delivery?

    Explore what newly published CBtru® pharmacokinetic data means for solid oral drug development—and why clinical evidence underpins meaningful innovation.

  • From compliance to confidence: how pharmaceutical quality management is evolving

    From compliance to confidence: how pharmaceutical quality management is evolving

    Discover how pharmaceutical quality management is advancing through proactive strategies that reduce risk, improve visibility, and support compliance.

How can we help you?

  • New partnership request

    Have an idea for a new project, a groundbreaking innovation, or a need for expert services? Let’s talk.

  • Sample request

    Don’t just take our word for it. Discover how our solutions can support your product development journey. 

  • Quote request

    Tell us about your project needs. We’ll build you a tailored quote.